Related Experiment Video
Updated: Aug 7, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Differential gene induction by type I and type II interferons and their combination
Corneliu Sanda1, Patrick Weitzel, Takuma Tsukahara
1Department of Biology, Indiana University, Bloomington, IN 47405, USA.
Type I and type II interferons (IFNs) modulate gene expression through common and distinct pathways. Combining IFN-alpha and IFN-gamma synergistically induces antiviral and apoptosis genes, explaining their combined therapeutic effects.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Type I and type II interferons (IFNs) utilize distinct receptors but share signaling pathways.
- Previous research indicates synergistic effects of combined Type I and Type II IFNs in antiviral and anti-tumor therapies.
Purpose of the Study:
- To investigate the differential and common gene expression patterns induced by Type I (IFN-alphacon1) and Type II (IFN-gamma1b) interferons in A549 cells.
- To elucidate the molecular basis for the synergistic effects of combined IFN-alpha and IFN-gamma treatment.
Main Methods:
- Gene expression analysis in A549 cells treated with IFN-alphacon1 and IFN-gamma1b.
- Quantitative assessment of gene induction using real-time kinetic RT-PCR.
Main Results:
- Both IFNs modulated a common set of genes, with distinct quantitative differences and specific gene sets regulated by each.
- IFN-gamma1b significantly induced genes involved in signaling, apoptosis, cytokine interactions, and the complement pathway.
- A subset of antiviral, apoptosis-related (TRAIL, caspases), and chemokine genes (RANTES, CXCL10, CXCL11) were synergistically induced by the combination of IFN-alphacon1 and IFN-gamma1b.
Conclusions:
- The combination of Type I and Type II IFNs leads to synergistic induction of key antiviral and apoptosis-related genes.
- The observed synergistic gene induction provides a molecular explanation for the enhanced therapeutic efficacy of combined IFNs in vivo.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Type I Diabetes II: Pathophysiology
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
